Clinical Blog
Published: June 01, 2023

Improving Clinical Outcomes Through Data Capturing and Analysis: Insights From ATS 2023 (Part One)

Using digital technology, clinical teams have new opportunities to capture accurate, real-time patient data and leverage medically actionable insights to improve the delivery of care and provide more personalized services.

Propeller Health and ResMed presented several abstracts at the ATS 2023 International Conference in Washington D.C. on May 19-24, many of which examined how enhanced patient data collection can lead to improved clinical outcomes among asthma and COPD patients. Read brief summaries of each abstract below or click the links to view them online.

Adherence to controller therapy among patients with severe asthma enrolled in a 6-month digital intervention

Summary: Escalating patients with severe asthma to biologics is costly, making it critical to first determine if therapy failure is due to poor controller adherence. Researchers enrolled patients from severe asthma clinics in the United Kingdom in Propeller’s digital therapeutic platform to better understand patterns of inhaler use. Over six months, approximately two-thirds of patients maintained controller therapy adherence greater than 80%. Such insights on medication use can help clinicians make more informed decisions for patients who warrant escalation to biologic therapy.

View this abstract online.

Medication adherence in severe asthma patients enrolling in the NHLBI PrecISE study

Summary: Electronic monitoring can help inform clinical trial eligibility, such as in the National Heart, Lung, and Blood Institute (NHLBI) PrecISE trial — a multisite study investigating the effectiveness of precision intervention strategies for adults and children with severe asthma. Study participants’ controller therapy adherence was evaluated with Propeller’s electronic sensors, revealing that more than half of study participants met the eligibility threshold of 70% controller adherence. Further, more patients over the age of 40 years reached the study eligibility threshold as compared to their younger counterparts. Such insights can inform smart study enrollment and determine recruitment strategies by confirming adherence eligibility and evaluating whether uncontrolled asthma is due to poor adherence. 

View this abstract online.

Summary: Researchers sought to identify early signals of worsening symptoms that could lead to exacerbations by analyzing trends in digitally-captured inhaler use and GPS-derived mobility in patients with COPD. Increased rescue and controller inhaler use was observed prior to high-puff days, suggesting that these behaviors may be early indicators of worsening symptoms. Mobility behavior also deviated from normal patterns before a high-puff day, which warrants further exploration. Identifying early warning signs of worsening COPD symptoms can help providers intervene earlier and possibly offset more costly acute care.

View this abstract online.

For any questions about Propeller’s peer-reviewed clinical research, please reach out to

Explore more insights from ATS 2023

Leveraging Claims Data to Improve Treatment Plans: Insights From ATS 2023 (Part Two)

Advancing Equity for Respiratory Patients Through Public Health Research: Insights From ATS 2023 (Part Three)

You Might Also Like

To Boost ROI, Life Sciences Needs To Deliver What HCPs Want: Digital Companions
Today’s evolving healthcare landscape is placing increasing emphasis on whole-person care. The shift has led healthcare professionals (HCPs) to seek digital solutions that support them in creating personalized and engaging care journeys for their patients. Therefore, if life sciences wants to drive financial returns now and stay ahead in today’s competitive healthcare market, they must […]
Life Sciences Is Using Digital Companions To Create Patient-Centric Drug Experiences — And Boosting ROI in the Process
The future of healthcare revolves around creating a patient-centric ecosystem. In today’s landscape, 81% of patients report being unsatisfied with their healthcare experience.1 One of the key drivers of their dissatisfaction? Lack of patient involvement: As many as 90% of patients want shared decision-making with their physician.2 Digital companions — beyond-the-pill digital solutions that deliver […]
The Critical Prescription for Success: 4 Direct Returns Life Sciences Can Realize From a Digital Companion
Digital health’s critical role in transforming healthcare and drug delivery is not a vision for a distant future — it’s the present reality. In the past three years, the top five life sciences companies have announced more than 50 investments in digital health technology companies and partnerships.1 Life sciences is transforming traditional products into data-rich, […]